{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996205345703316"]
[null,null,"Titolo",null,"Textbook of hemophilia [[electronic resource] /] / edited by Christine A. Lee, Erik E. Berntorp, W. Keith Hoots ; with a foreword by Louis M. Aledort"]
[null,null,"Pubbl/distr/stampa",null,"Malden, Mass. ; ; Oxford, : Blackwell Pub., 2005"]
[null,null,"ISBN",null,"1-280-19695-5"]
[{"$nulls":4},"9786610196951"]
[{"$nulls":4},"0-470-98712-X"]
[{"$nulls":4},"1-4051-4386-X"]
[null,null,"Descrizione fisica",null,"xii, 400 p., [4] p. of plates : ill. (some col.)"]
[null,null,"Disciplina",null,"616.1/572"]
[null,null,"Soggetti",null,"Hemophilia"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Introduction -- Hemophilia A -- Inhibitors to factor VIII -- Acquired hemophilia -- Hemophilia B -- Pharmacokinetics of factors VIII and IX -- Pediatrics -- Products used to treat hemophilia -- Musculoskeletal -- Transfusion-transmitted disease -- Gene therapy -- Laboratory -- Obstetrics and gynecology -- von Willebrand disease -- Treatment of von Willebrand disease -- Rare bleeding disorders -- Quality of life -- Economics -- Comprehensive care and delivery of care."]